<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>NC Health Innovation District | Clinical Trials Innovation | Activity</title>
	<link>https://nchid.com/programs/clinical-trials-innovation/</link>
	<atom:link href="https://nchid.com/programs/clinical-trials-innovation/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the group, Clinical Trials Innovation.</description>
	<lastBuildDate>Thu, 05 Feb 2026 11:23:45 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=2.8.70</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">9926e64d8b2d14ae2c119e823573b9a7</guid>
				<title>Jennifer joined the group Clinical Trials Innovation</title>
				<link>https://nchid.com/activity/p/159/</link>
				<pubDate>Thu, 29 Jun 2023 15:13:52 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9926e64d8b2d14ae2c119e823573b9a7</guid>
				<title>Michael Levy joined the group Clinical Trials Innovation</title>
				<link>https://nchid.com/activity/p/158/</link>
				<pubDate>Thu, 29 Jun 2023 15:13:52 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4896b943da4469b8ab99d77118047620</guid>
				<title>J. Kevin Tugman changed the description of the group Clinical Trials Innovation from "Clinical trials are the foundation of medical advancements, playing a vital role in the development of new treatments and interventions. This community of practice is dedicated to driving innovation in clinical trials, enhancing their efficiency, inclusivity, and patient-centricity through digital health technologies.
Digital health has the potential to revolutionize clinical trials, making them more efficient and patient friendly. Electronic health records can streamline participant recruitment, while mobile health applications and wearable devices can facilitate remote data collection, reducing the need for frequent in-person visits. AI and machine learning algorithms can analyze trial data more quickly and accurately, accelerating the discovery of new insights.

Moreover, virtual or decentralized clinical trials, which leverage digital technologies to allow participation from home, can make trials more accessible. They can enable the inclusion of diverse populations who may have been previously excluded due to geographical or logistical barriers, thereby enhancing the generalizability of trial results.

However, the adoption of these innovations comes with challenges, such as data privacy and security, regulatory compliance, and ensuring data quality and integrity. This community serves as a platform to discuss these issues, share best practices, and develop solutions.

The community brings together a wide range of stakeholders, including researchers, healthcare professionals, and technology experts. Their collective expertise and experiences contribute to a robust discussion around the future of clinical trials.

The ultimate goal of this community is to foster a future where clinical trials are more efficient, inclusive, and patient-centered. In this envisioned future, digital health technologies play a crucial role in driving innovation in clinical trials, making them more efficient, accessible, and patient-friendly." to "Clinical trials are the foundation of medical advancements, playing a vital role in the development of new treatments and interventions. This community of practice is dedicated to driving innovation in clinical trials, enhancing their efficiency, inclusivity, and patient-centricity through digital health technologies.

Digital health has the potential to revolutionize clinical trials, making them more efficient and patient friendly. Electronic health records can streamline participant recruitment, while mobile health applications and wearable devices can facilitate remote data collection, reducing the need for frequent in-person visits. AI and machine learning algorithms can analyze trial data more quickly and accurately, accelerating the discovery of new insights.

Moreover, virtual or decentralized clinical trials, which leverage digital technologies to allow participation from home, can make trials more accessible. They can enable the inclusion of diverse populations who may have been previously excluded due to geographical or logistical barriers, thereby enhancing the generalizability of trial results.

However, the adoption of these innovations comes with challenges, such as data privacy and security, regulatory compliance, and ensuring data quality and integrity. This community serves as a platform to discuss these issues, share best practices, and develop solutions.

The community brings together a wide range of stakeholders, including researchers, healthcare professionals, and technology experts. Their collective expertise and experiences contribute to a robust discussion around the future of clinical trials.

The ultimate goal of this community is to foster a future where clinical trials are more efficient, inclusive, and patient-centered. In this envisioned future, digital health technologies play a crucial role in driving innovation in clinical trials, making them more efficient, accessible, and patient-friendly."</title>
				<link>https://nchid.com/activity/p/54/</link>
				<pubDate>Mon, 15 May 2023 19:40:30 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8ad04e554053446bbee88b07cfe8e290</guid>
				<title>J. Kevin Tugman changed the description of the group Clinical Trials Innovation from "Clinical trials are the foundation of medical advancements, playing a vital role in the development of new treatments and interventions. This community of practice is dedicated to driving innovation in clinical trials, enhancing their efficiency, inclusivity, and patient-centricity through digital health technologies.

Digital health has the potential to revolutionize clinical trials, making them more efficient and patient friendly. Electronic health records can streamline participant recruitment, while mobile health applications and wearable devices can facilitate remote data collection, reducing the need for frequent in-person visits. AI and machine learning algorithms can analyze trial data more quickly and accurately, accelerating the discovery of new insights.

Moreover, virtual or decentralized clinical trials, which leverage digital technologies to allow participation from home, can make trials more accessible. They can enable the inclusion of diverse populations who may have been previously excluded due to geographical or logistical barriers, thereby enhancing the generalizability of trial results.

However, the adoption of these innovations comes with challenges, such as data privacy and security, regulatory compliance, and ensuring data quality and integrity. This community serves as a platform to discuss these issues, share best practices, and develop solutions.

The community brings together a wide range of stakeholders, including researchers, healthcare professionals, and technology experts. Their collective expertise and experiences contribute to a robust discussion around the future of clinical trials.

The ultimate goal of this community is to foster a future where clinical trials are more efficient, inclusive, and patient-centered. In this envisioned future, digital health technologies play a crucial role in driving innovation in clinical trials, making them more efficient, accessible, and patient-friendly." to "Clinical trials are the foundation of medical advancements, playing a vital role in the development of new treatments and interventions. This community of practice is dedicated to driving innovation in clinical trials, enhancing their efficiency, inclusivity, and patient-centricity through digital health technologies.
Digital health has the potential to revolutionize clinical trials, making them more efficient and patient friendly. Electronic health records can streamline participant recruitment, while mobile health applications and wearable devices can facilitate remote data collection, reducing the need for frequent in-person visits. AI and machine learning algorithms can analyze trial data more quickly and accurately, accelerating the discovery of new insights.

Moreover, virtual or decentralized clinical trials, which leverage digital technologies to allow participation from home, can make trials more accessible. They can enable the inclusion of diverse populations who may have been previously excluded due to geographical or logistical barriers, thereby enhancing the generalizability of trial results.

However, the adoption of these innovations comes with challenges, such as data privacy and security, regulatory compliance, and ensuring data quality and integrity. This community serves as a platform to discuss these issues, share best practices, and develop solutions.

The community brings together a wide range of stakeholders, including researchers, healthcare professionals, and technology experts. Their collective expertise and experiences contribute to a robust discussion around the future of clinical trials.

The ultimate goal of this community is to foster a future where clinical trials are more efficient, inclusive, and patient-centered. In this envisioned future, digital health technologies play a crucial role in driving innovation in clinical trials, making them more efficient, accessible, and patient-friendly."</title>
				<link>https://nchid.com/activity/p/53/</link>
				<pubDate>Mon, 15 May 2023 19:40:17 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f3ee4d1f0a7e601431794aa6cd8e32fe</guid>
				<title>J. Kevin Tugman changed the description of the group Clinical Trials Innovation from "Description information is needed here." to "Clinical trials are the foundation of medical advancements, playing a vital role in the development of new treatments and interventions. This community of practice is dedicated to driving innovation in clinical trials, enhancing their efficiency, inclusivity, and patient-centricity through digital health technologies.

Digital health has the potential to revolutionize clinical trials, making them more efficient and patient friendly. Electronic health records can streamline participant recruitment, while mobile health applications and wearable devices can facilitate remote data collection, reducing the need for frequent in-person visits. AI and machine learning algorithms can analyze trial data more quickly and accurately, accelerating the discovery of new insights.

Moreover, virtual or decentralized clinical trials, which leverage digital technologies to allow participation from home, can make trials more accessible. They can enable the inclusion of diverse populations who may have been previously excluded due to geographical or logistical barriers, thereby enhancing the generalizability of trial results.

However, the adoption of these innovations comes with challenges, such as data privacy and security, regulatory compliance, and ensuring data quality and integrity. This community serves as a platform to discuss these issues, share best practices, and develop solutions.

The community brings together a wide range of stakeholders, including researchers, healthcare professionals, and technology experts. Their collective expertise and experiences contribute to a robust discussion around the future of clinical trials.

The ultimate goal of this community is to foster a future where clinical trials are more efficient, inclusive, and patient-centered. In this envisioned future, digital health technologies play a crucial role in driving innovation in clinical trials, making them more efficient, accessible, and patient-friendly."</title>
				<link>https://nchid.com/activity/p/52/</link>
				<pubDate>Mon, 15 May 2023 19:39:34 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
		